These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23520206)

  • 21. Haemophagocytic lymphohistiocytosis with collapsing lupus podocytopathy as an unusual manifestation of systemic lupus erythematosus with APOL1 double-risk alleles.
    Chokshi B; D'Agati V; Bizzocchi L; Johnson B; Mendez B; Jim B
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30642866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should kidney donors be genotyped for APOL1 risk alleles?
    Freedman BI; Julian BA
    Kidney Int; 2015 Apr; 87(4):671-3. PubMed ID: 25826538
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
    Ito K; Bick AG; Flannick J; Friedman DJ; Genovese G; Parfenov MG; Depalma SR; Gupta N; Gabriel SB; Taylor HA; Fox ER; Newton-Cheh C; Kathiresan S; Hirschhorn JN; Altshuler DM; Pollak MR; Wilson JG; Seidman JG; Seidman C
    Circ Res; 2014 Feb; 114(5):845-50. PubMed ID: 24379297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI).
    Abid Q; Best Rocha A; Larsen CP; Schulert G; Marsh R; Yasin S; Patty-Resk C; Valentini RP; Adams M; Baracco R
    Am J Kidney Dis; 2020 Feb; 75(2):287-290. PubMed ID: 31601430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
    Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
    Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein L1 risk genotypes in Ghanaian patients with systemic lupus erythematosus: a prospective cohort study.
    Blazer A; Dey ID; Nwaukoni J; Reynolds M; Ankrah F; Algasas H; Ahmed T; Divers J
    Lupus Sci Med; 2021 Jan; 8(1):. PubMed ID: 33461980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.
    Blazer A; Wang B; Simpson D; Kirchhoff T; Heffron S; Clancy RM; Heguy A; Ray K; Snuderl M; Buyon JP
    PLoS One; 2017; 12(8):e0182483. PubMed ID: 28850570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity-related glomerulopathy in the presence of APOL1 risk alleles.
    Valdez Imbert R; Hti Lar Seng NS; Stokes MB; Jim B
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35985743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
    Lipkowitz MS; Freedman BI; Langefeld CD; Comeau ME; Bowden DW; Kao WH; Astor BC; Bottinger EP; Iyengar SK; Klotman PE; Freedman RG; Zhang W; Parekh RS; Choi MJ; Nelson GW; Winkler CA; Kopp JB;
    Kidney Int; 2013 Jan; 83(1):114-20. PubMed ID: 22832513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
    Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
    Larsen CP; Beggs ML; Saeed M; Ambruzs JM; Cossey LN; Messias NC; Walker PD; Freedman BI
    Mod Pathol; 2015 Jan; 28(1):95-102. PubMed ID: 25081748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
    Mukamal KJ; Tremaglio J; Friedman DJ; Ix JH; Kuller LH; Tracy RP; Pollak MR
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):398-403. PubMed ID: 26634651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. African American living-kidney donors should be screened for APOL1 risk alleles.
    Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
    Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.
    Atta MG; Estrella MM; Kuperman M; Foy MC; Fine DM; Racusen LC; Lucas GM; Nelson GW; Warner AC; Winkler CA; Kopp JB
    Kidney Int; 2012 Aug; 82(3):338-43. PubMed ID: 22495294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collapsing Glomerulopathy.
    Koirala A; Akilesh S; Jefferson JA
    Adv Kidney Dis Health; 2024 Jul; 31(4):290-298. PubMed ID: 39084754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
    Nadkarni GN; Galarneau G; Ellis SB; Nadukuru R; Zhang J; Scott SA; Schurmann C; Li R; Rasmussen-Torvik LJ; Kho AN; Hayes MG; Pacheco JA; Manolio TA; Chisholm RL; Roden DM; Denny JC; Kenny EE; Bottinger EP
    J Am Coll Cardiol; 2017 Mar; 69(12):1564-1574. PubMed ID: 28335839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
    Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Hicks PJ; Palmer ND; Adams PL; Palanisamy A; Reeves-Daniel AM; Divers J
    Am J Transplant; 2015 Jun; 15(6):1615-22. PubMed ID: 25809272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1-second gene interactions.
    Langefeld CD; Comeau ME; Ng MCY; Guan M; Dimitrov L; Mudgal P; Spainhour MH; Julian BA; Edberg JC; Croker JA; Divers J; Hicks PJ; Bowden DW; Chan GC; Ma L; Palmer ND; Kimberly RP; Freedman BI
    Kidney Int; 2018 Sep; 94(3):599-607. PubMed ID: 29885931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI; Murea M
    Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population-based risk assessment of APOL1 on renal disease.
    Friedman DJ; Kozlitina J; Genovese G; Jog P; Pollak MR
    J Am Soc Nephrol; 2011 Nov; 22(11):2098-105. PubMed ID: 21997396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.